Barely Significant
← all phrases

“highly significant”

132,143 sentences · 132,143 papers · 160,126 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013)

In the literature

highly significantp = 0.0050.1× alphaqualifiedgold
Among these haplotypes, the single-plant yields observed were 29.81 ± 10.24 g, 37.71 ± 14.41 g, 36.64 ± 16.43 g, and 42.32 ± 11.73 g for the 1st, 2nd, 3rd, and 4th haplotypes, respectively, and the p value for the mean difference between the haplotypes was found to be highly significant ( p = 0.005) ( Figure 10 , Table 5 ). 2.10.
highly significantP < 0.0050.1× alphaqualifiedgold
Whereas there was no statistically significant difference in disease scores between iNOS KO and wild-type mice that did not receive IL-12 ( P = 0.74), scores of IL-12–treated iNOS KO and IL-12–treated wild-type mice differed at the highly significant probability value of P < 0.005.
highly significantp = .0050.1× alphaqualifiedgold
reached borderline significancep = .0661.3× alphagold
The analyses of the BIS subscales showed that this differential effect was particularly attributable to motor impulsivity (i.e., acting without thinking), where the group*time interaction reached borderline significance ( p = .066, see also Table S4 in Supplement) and post hoc tests indicated a highly significant improvement in the active group ( p = .005) but no significant change in the sham group ( p = .58).
highly significantP < 0.0050.1× alphaqualifiedgold
When the mean decrease in growth rate due to parasite inoculum size for each dataset was plotted against mean initial growth rate, a highly significant relationship (r 2 = 0.7546, P < 0.005) was noted, even when the relationship between parasite population growth rate and inoculum size within individual datasets was non-significant (Fig. 3b ).
highly significantp = 0.0050.1× alphaqualifiedgold
There was no statistically significant difference in disease duration since the introduction of the first csDMARD or bDMARD treatment, but the duration of disease at the introduction of the current bDMARD treatment was significantly shorter in the reduced-dose group than in the stable-dose group (9.7 vs 12.1 years, p = 0.034) (Table 1 ). In addition, we noted that there were proportionately more patients treated concurrently with MTX in the reduced-dose group than in the stable-dose group, and the difference was highly significant (86.7% vs 73.8%, p = 0.005).
highly significantP < 0.0050.1× alphaqualifiedgold
We designed and transfected three ZNF667‐AS1 silencing sequences (Table S1 ) and found that the interference efficiency of si‐ZNF667‐AS1 with siRNA‐1 and siRNA‐3 sequences was significant ( P < 0.05), among which the interference efficiency of siRNA‐1 was highly significant ( P < 0.005), while that of siRNA‐2 was not significant ( P > 0.05; Fig. 2 C,F).
highly significantP = 0.0050.1× alphaqualifiedgold
However, significant reductions in HbA1c%, HbA1c mmol/mol (0.36% and 3.96 mmol/mol, both P ≤ 0.001) and systolic blood pressure (3.84 mmHg, P = 0.004) were seen at the 6-month follow-up. Association of step count change with inflammatory and clinical markers of T2DM and CVD An increase in daily step count was associated with a highly significant decrease in IL6 ( P = 0.005) which represented a 0.81 ng/L reduction per 1000 steps, equating to a 13% decrease.